# Innoviva (INVA) — Earnings

INVA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/inva/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | $0.77 |
| EPS estimate | $0.50 |
| EPS surprise | +54.31% |
| Revenue surprise | +8.96% |
| Revenue | $100.3M |
| Revenue estimate | $92.0M |
| Reported | Aug 6, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1080014/000095017025104126/inva-20250630.htm) |

Innoviva reported Q2 2025 results on August 6, 2025. Earnings per share were $0.77, ahead of the $0.50 estimate by 54.31%. Revenue was $100.3 million, above the $92.0 million estimate. Compared with Q2 2024, EPS swung from a $0.55 loss to a profit, while revenue was nearly flat, up from $99.9 million.

Earnings in the table swing widely from quarter to quarter, more than revenue does. Annual EPS was $2.78 in 2021, $2.07 in 2022 and $2.18 in 2023, then dropped to $0.19 in 2024. Revenue was $391.9 million in 2021, $331.4 million in 2022, $310.5 million in 2023 and $358.7 million in 2024. The best quarter shown was Q3 2022, at $2.80 per share, and the worst was Q4 2022, a loss of $0.98. Three of the 20 quarters were losses, including Q1 2025 at $0.74 per share. The first half of 2025 brought $188.9 million of revenue, 6.5% more than a year earlier. Over the 20 quarters, Innoviva beat the EPS estimate ten times and missed ten times.

The table shows no report after Q2 2025. In the period covered, third-quarter results came out in late October or early November.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 6, 2025 | $0.50 | $0.77 | 54.31% | $92.0M | $100.3M |
| Q1 2025 | May 7, 2025 | $0.29 | −$0.74 | -351.87% | $82.7M | $88.6M |
| Q4 2024 | Feb 26, 2025 | $0.37 | $0.26 | -29.73% | $86.8M | $91.8M |
| Q3 2024 | Nov 6, 2024 | $0.27 | $0.02 | -92.45% | $76.9M | $89.5M |
| Q2 2024 | Jul 31, 2024 | $0.24 | −$0.55 | -334.04% | $74.7M | $99.9M |
| Q1 2024 | May 8, 2024 | $0.17 | $0.46 | 170.59% | $68.0M | $77.5M |
| Q4 2023 | Feb 29, 2024 | $0.23 | $0.76 | 230.43% | $75.5M | $85.8M |
| Q3 2023 | Nov 1, 2023 | $0.27 | $0.98 | 262.96% | $75.7M | $67.3M |
| Q2 2023 | Aug 2, 2023 | $0.26 | $0.02 | -92.31% | $67.9M | $81.0M |
| Q1 2023 | May 9, 2023 | $0.23 | $0.42 | 82.61% | $62.0M | $76.4M |
| Q4 2022 | Feb 28, 2023 | $0.23 | −$0.98 | -535.56% | $58.9M | $65.8M |
| Q3 2022 | Nov 9, 2022 | $1.53 | $2.80 | 83.01% | $62.6M | $67.3M |
| Q2 2022 | Jul 27, 2022 | $1.47 | $0.05 | -96.59% | $214.8M | $108.2M |
| Q1 2022 | Apr 28, 2022 | $0.44 | $0.20 | -54.55% | $86.4M | $90.1M |
| Q4 2021 | Feb 9, 2022 | $0.41 | $0.14 | -65.85% | — | $107.7M |
| Q3 2021 | Oct 27, 2021 | $0.43 | $0.90 | 109.30% | — | $97.9M |
| Q2 2021 | Jul 28, 2021 | $0.29 | $0.90 | 210.34% | — | $100.8M |
| Q1 2021 | Apr 28, 2021 | −$0.01 | $0.84 | 8500.00% | — | $85.5M |
| Q4 2020 | Feb 3, 2021 | $0.40 | $0.48 | 20.00% | $75.3M | $90.5M |
| Q3 2020 | Oct 28, 2020 | $0.42 | $0.26 | -38.10% | $71.1M | $88.7M |

## Frequently Asked Questions

### When did Innoviva (INVA) last report earnings?

Innoviva last reported on Aug 6, 2025, covering fiscal Q2 2025.

### Did INVA beat earnings estimates?

Yes. Innoviva reported EPS of $0.77 for Q2 2025 against a $0.50 estimate — a 54.31% beat.

### How much revenue did INVA report last quarter?

Innoviva reported $100.3M in revenue for Q2 2025, against a consensus estimate of $92.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).